Lv45
516 积分 2024-03-31 加入
Sex differences in renal transporters: assessment and functional consequences
4天前
已完结
Pneumothorax in lung cancer following anlotinib treatment: A case report
10天前
已完结
Combined inhibition of MET and VEGF enhances therapeutic efficacy of EGFR TKIs in EGFR-mutant non-small cell lung cancer with concomitant aberrant MET activation
11天前
已完结
Pneumothorax in lung cancer following anlotinib treatment: A case report
11天前
已完结
Primary Lung Cancer Complicated with Pneumothorax
11天前
已完结
Mining and analysis of adverse event signals of vandetanib based on the FAERS database
12天前
已完结
Postmarketing safety of anaplastic lymphoma kinase (ALK) inhibitors: an analysis of the FDA Adverse Event Reporting System (FAERS)
12天前
已完结
Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat
18天前
已完结
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial
20天前
已完结
A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)
22天前
已完结
皖公网安备34019202002308
